Description: In late 2021, U.S. Congress passed the Consolidated Appropriations Act (CCA), which requires group health plans and health insurers to submit information regarding the costs of prescription drug costs and other health care services each year to the federal government. Learn how this data can be useful to anyone responsible for forecasting and budgeting.

Description: This study of mortality on deferred Variable annuities over the period 1991-1995 was designed to test the adequacy of the 1994 MGDB Valuation Mortality Table to cover presumed extra mortality on Variable annuities VAs with Substantial Minimum Guaranteed Death Benefits MGDBs as compared with VAs with Minimal MGDBs. A parallel study of Fixed Annuity experience was carried out as a control. Expected deaths were computed also on the Annuity 2000 Table. The results raise questions as to its continuing safety as a valuation table for individual annuities. The study also shows that mortality levels on Qualified NonPension Trust business are significantly lower than on Nonqualified business.

Description: ACA risk adjustment is intended to "bridge the gap" between allowed rates and actuarial rates. If risk adjustment methodology is not bridging that gap & becomes an additional input to pricing formulae, it is not serving its intended purpose.

Description: 2021 ImpACT Conference - Session 3D: Individual Life Experience: Committee, Contest, COVID-19 and Data Update 10.26.21 Recording

Description: In late 2021, U.S. Congress passed the Consolidated Appropriations Act (CCA), which requires group health plans and health insurers to submit information regarding the costs of prescription drug costs and other health care services each year to the federal government. Learn how this data can be useful to anyone responsible for forecasting and budgeting.

Description: In 2020 the Actuarial Innovation and Technology Steering Committee held a data visualization contest. Entries showed a variety of strengths including smart use of tools, user-friendly dashboards, and displays paired with actuarial analysis that can lead an end-user through a process of discovery. In this webcast a data visualization expert will review the winning entries with the contestants. We'll discuss how the different strengths of these entries can be combined to create a powerful tool for communication and understanding.

Description: SARS-CoV2 will impact our post-pandemic future. Morbidity more than mortality will impact the life and health business in the mid-term. But how does this temporary disruption in health care elicit long-tail implications on other common diseases and changes in lifestyles? Find out how mid-term pricing could be affected using one case scenario and also show how mental health will particularly shape the post-pandemic future (individually and societal), not only due to long COVID. Review the experience of the insured policies and discuss future ideas for COVID-19 research at the Society of Actuaries Research Institute. Consider recent causes of death studies, as well as reported claims analyses to help expedite the analysis of recent experience. Join us where experts from both the medical and actuarial disciplines join forces to discuss this important topic.

Description: The South African life insurance industry contains the largest life insurance market in Africa, it is highly sophisticated and highly regulated. In the years 2020 and2021, the industry suffered significant mortality losses due toCovid-19. What can we learn from this experience in South Africa?

Description: Future mortality improvement has been a common assumption in life insurance and annuity pricing and forecasting for many years. However, experience over the last decade suggests this might be an assumption that merits reconsideration in the United States. This article will take a closer look at factors that impact mortality improvement trends and discuss why insurers may want to reevaluate product designs to better manage the associated mortality risk. We then introduce a product idea with this in mind, where premiums are based on a life expectancy index and insurers share the risk (and opportunity) or mortality improvement with policyholders.

Description: sources of Health Care data Issue No. 37.